Market closedNon-fractional

Repare Therapeutics/RPTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Repare Therapeutics

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

Ticker

RPTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Montréal, Canada

Employees

179

RPTX Metrics

BasicAdvanced
$165M
Market cap
-
P/E ratio
-$1.08
EPS
0.70
Beta
-
Dividend rate
$165M
0.7
8.331
8.217
0.242
1.198
-14.75%
-18.91%
1.675
0.72
0.72
-1.931
-28.62%
55.68%
587.61%
-20.47%

What the Analysts think about RPTX

Analyst Ratings

Majority rating from 7 analysts.
Buy

RPTX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
25.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$52M
303.08%
Net income
$13M
-146.79%
Profit margin
25.00%
-111.61%

RPTX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 1,809.13%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.28
-$0.45
-$0.67
$0.30
-
Expected
-$0.78
-$0.86
-$0.36
$0.02
-$0.87
Surprise
-64.10%
-47.60%
86.85%
1,809.13%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Repare Therapeutics stock?

Repare Therapeutics (RPTX) has a market cap of $165M as of July 23, 2024.

What is the P/E ratio for Repare Therapeutics stock?

The price to earnings (P/E) ratio for Repare Therapeutics (RPTX) stock is 0 as of July 23, 2024.

Does Repare Therapeutics stock pay dividends?

No, Repare Therapeutics (RPTX) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Repare Therapeutics dividend payment date?

Repare Therapeutics (RPTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Repare Therapeutics?

Repare Therapeutics (RPTX) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Repare Therapeutics stock

Buy or sell Repare Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing